{"transactions":[{"id":1911472,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":114091,"kind":"organization","name":"Chicago Pacific Founders UGP, LLC","position":1,"cik":"0001897558","reported_name":"Chicago Pacific Founders UGP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114092,"kind":"organization","name":"Chicago Pacific Founders GP, L.P.","position":2,"cik":"0001898470","reported_name":"Chicago Pacific Founders GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114093,"kind":"organization","name":"CHICAGO PACIFIC FOUNDERS FUND, L.P.","position":3,"cik":"0001621663","reported_name":"CHICAGO PACIFIC FOUNDERS FUND, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114094,"kind":"organization","name":"CHICAGO PACIFIC FOUNDERS FUND-A, L.P.","position":4,"cik":"0001621662","reported_name":"CHICAGO PACIFIC FOUNDERS FUND-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114095,"kind":"organization","name":"CHICAGO PACIFIC FOUNDERS FUND-B, L.P.","position":5,"cik":"0001674021","reported_name":"CHICAGO PACIFIC FOUNDERS FUND-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Common Stock Purchase Warrant","published_at":"2023-04-28T18:12:45.000Z","date":"2023-04-06","kind":"purchase","planned":false,"acquired":true,"shares":966253,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 6, 2023, P3 Health Partners Inc. (the \"Issuer\") issued units to Chicago Pacific Founders Fund, L.P. (\"Fund I\"), Chicago Pacific Founders Fund-A, L.P. (\"Fund I-A\") and Chicago Pacific Founders Fund-B, L.P. (\"Fund I-B\") at a price of $1.1180 per unit. Each unit consists of one share of Class A Common Stock, par value $0.0001 per share (the \"Common Stock\"), and 0.75 of a warrant (\"Common Warrants\") to purchase one share of Common Stock at an exercise price of $1.13. Each of Fund I, Fund I-A and Fund I-B elected to receive pre-funded warrants (\"Pre-Funded Warrants\", and together with Common Warrants, the \"Warrants\") to purchase Common Stock in lieu of a portion of their Common Stock."},{"field":"shares","element":"transactionShares","label":"F8","text":"Includes (i) 861,149 shares of Common Stock issuable upon exercise of Pre-Funded Warrants directly acquired by Fund I, (ii) 33,447 shares of Common Stock issuable upon exercise of Pre-Funded Warrants acquired by Fund I-A and (iii) 71,657 shares of Common Stock issuable upon exercise of Pre-Funded Warrants acquired by Fund I-B."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 6, 2023, P3 Health Partners Inc. (the \"Issuer\") issued units to Chicago Pacific Founders Fund, L.P. (\"Fund I\"), Chicago Pacific Founders Fund-A, L.P. (\"Fund I-A\") and Chicago Pacific Founders Fund-B, L.P. (\"Fund I-B\") at a price of $1.1180 per unit. Each unit consists of one share of Class A Common Stock, par value $0.0001 per share (the \"Common Stock\"), and 0.75 of a warrant (\"Common Warrants\") to purchase one share of Common Stock at an exercise price of $1.13. Each of Fund I, Fund I-A and Fund I-B elected to receive pre-funded warrants (\"Pre-Funded Warrants\", and together with Common Warrants, the \"Warrants\") to purchase Common Stock in lieu of a portion of their Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Exercisable immediately, provided that the Reporting Person may not exercise any portion of any Warrant, which, upon giving effect or immediately prior to such exercise, would cause the aggregate number of shares of Common Stock beneficially owned by the Reporting Person (together with its affiliates) to exceed 49.99% of the number of shares of Common Stock issued and outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the Warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Pre-Funded Warrants and the right to purchase securities upon the exercise of the Pre-Funded Warrants will terminate upon the consummation of (A) a sale, conveyance, disposal, or encumbrance of all or substantially all of the Issuer's property or business or the Issuer's merger into or consolidation with any other corporation (other than a wholly owned subsidiary corporation) or (B) any other transaction or series of related transactions in which more than fifty percent (50%) of the voting power of the Issuer is disposed of and the proceeds thereof are paid to then-existing stockholders of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Chicago Pacific Founders UGP, LLC (\"UGP\") is the general partner of Chicago Founders GP, LP (\"GP\"), the general partner of each of Fund I, Fund I-A and Fund I-B. As a result, UGP has the power to vote and dispose of the Issuer's securities held by Fund I, Fund I-A and Fund I-B (the \"Underlying Securities\"). Each of UGP and GP disclaims beneficial ownership for the amount in excess of their pecuniary interest in the Underlying Securities."}],"balance_after":966253,"derivative":{"exercise_price":0.0001,"underlying":"Class A Common\nStock","underlying_shares":966253},"source":{"system":"sec-edgar","filing":"0000899243-23-011890","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1898470/000089924323011890/doc4.xml","form_type":"4"}},{"id":1911471,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":114091,"kind":"organization","name":"Chicago Pacific Founders UGP, LLC","position":1,"cik":"0001897558","reported_name":"Chicago Pacific Founders UGP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114092,"kind":"organization","name":"Chicago Pacific Founders GP, L.P.","position":2,"cik":"0001898470","reported_name":"Chicago Pacific Founders GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114093,"kind":"organization","name":"CHICAGO PACIFIC FOUNDERS FUND, L.P.","position":3,"cik":"0001621663","reported_name":"CHICAGO PACIFIC FOUNDERS FUND, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114094,"kind":"organization","name":"CHICAGO PACIFIC FOUNDERS FUND-A, L.P.","position":4,"cik":"0001621662","reported_name":"CHICAGO PACIFIC FOUNDERS FUND-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114095,"kind":"organization","name":"CHICAGO PACIFIC FOUNDERS FUND-B, L.P.","position":5,"cik":"0001674021","reported_name":"CHICAGO PACIFIC FOUNDERS FUND-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock Purchase Warrant","published_at":"2023-04-28T18:12:45.000Z","date":"2023-04-06","kind":"purchase","planned":false,"acquired":true,"shares":4279031,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 6, 2023, P3 Health Partners Inc. (the \"Issuer\") issued units to Chicago Pacific Founders Fund, L.P. (\"Fund I\"), Chicago Pacific Founders Fund-A, L.P. (\"Fund I-A\") and Chicago Pacific Founders Fund-B, L.P. (\"Fund I-B\") at a price of $1.1180 per unit. Each unit consists of one share of Class A Common Stock, par value $0.0001 per share (the \"Common Stock\"), and 0.75 of a warrant (\"Common Warrants\") to purchase one share of Common Stock at an exercise price of $1.13. Each of Fund I, Fund I-A and Fund I-B elected to receive pre-funded warrants (\"Pre-Funded Warrants\", and together with Common Warrants, the \"Warrants\") to purchase Common Stock in lieu of a portion of their Common Stock."},{"field":"shares","element":"transactionShares","label":"F7","text":"Includes (i) 3,813,578 shares of Common Stock issuable upon exercise of Common Warrants directly acquired by Fund I, (ii) 148,120 shares of Common Stock issuable upon exercise of Common Warrants directly acquired by Fund I-A, and (iii) 317,333 shares of Common Stock issuable upon exercise of Common Warrants directly acquired by Fund I-B."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 6, 2023, P3 Health Partners Inc. (the \"Issuer\") issued units to Chicago Pacific Founders Fund, L.P. (\"Fund I\"), Chicago Pacific Founders Fund-A, L.P. (\"Fund I-A\") and Chicago Pacific Founders Fund-B, L.P. (\"Fund I-B\") at a price of $1.1180 per unit. Each unit consists of one share of Class A Common Stock, par value $0.0001 per share (the \"Common Stock\"), and 0.75 of a warrant (\"Common Warrants\") to purchase one share of Common Stock at an exercise price of $1.13. Each of Fund I, Fund I-A and Fund I-B elected to receive pre-funded warrants (\"Pre-Funded Warrants\", and together with Common Warrants, the \"Warrants\") to purchase Common Stock in lieu of a portion of their Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Exercisable immediately, provided that the Reporting Person may not exercise any portion of any Warrant, which, upon giving effect or immediately prior to such exercise, would cause the aggregate number of shares of Common Stock beneficially owned by the Reporting Person (together with its affiliates) to exceed 49.99% of the number of shares of Common Stock issued and outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the Warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Common Warrants and the right to purchase securities upon the exercise of the Common Warrants will terminate upon the earliest to occur of the following: (i) April 6, 2028; and (ii) the consummation of (A) a sale, conveyance, disposal, or encumbrance of all or substantially all of the Issuer's property or business or the Issuer's merger into or consolidation with any other corporation (other than a wholly owned subsidiary corporation) or (B) any other transaction or series of related transactions in which more than fifty percent (50%) of the voting power of the Issuer is disposed of and the proceeds thereof are paid to then-existing stockholders of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Chicago Pacific Founders UGP, LLC (\"UGP\") is the general partner of Chicago Founders GP, LP (\"GP\"), the general partner of each of Fund I, Fund I-A and Fund I-B. As a result, UGP has the power to vote and dispose of the Issuer's securities held by Fund I, Fund I-A and Fund I-B (the \"Underlying Securities\"). Each of UGP and GP disclaims beneficial ownership for the amount in excess of their pecuniary interest in the Underlying Securities."}],"balance_after":4708211,"derivative":{"exercise_price":1.13,"underlying":"Class A Common\nStock","underlying_shares":4279031},"source":{"system":"sec-edgar","filing":"0000899243-23-011890","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1898470/000089924323011890/doc4.xml","form_type":"4"}},{"id":1911470,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":114091,"kind":"organization","name":"Chicago Pacific Founders UGP, LLC","position":1,"cik":"0001897558","reported_name":"Chicago Pacific Founders UGP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114092,"kind":"organization","name":"Chicago Pacific Founders GP, L.P.","position":2,"cik":"0001898470","reported_name":"Chicago Pacific Founders GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114093,"kind":"organization","name":"CHICAGO PACIFIC FOUNDERS FUND, L.P.","position":3,"cik":"0001621663","reported_name":"CHICAGO PACIFIC FOUNDERS FUND, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114094,"kind":"organization","name":"CHICAGO PACIFIC FOUNDERS FUND-A, L.P.","position":4,"cik":"0001621662","reported_name":"CHICAGO PACIFIC FOUNDERS FUND-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114095,"kind":"organization","name":"CHICAGO PACIFIC FOUNDERS FUND-B, L.P.","position":5,"cik":"0001674021","reported_name":"CHICAGO PACIFIC FOUNDERS FUND-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-04-28T18:12:45.000Z","date":"2023-04-06","kind":"purchase","planned":false,"acquired":true,"shares":4739120,"price":1.18,"value":5592161.6,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 6, 2023, P3 Health Partners Inc. (the \"Issuer\") issued units to Chicago Pacific Founders Fund, L.P. (\"Fund I\"), Chicago Pacific Founders Fund-A, L.P. (\"Fund I-A\") and Chicago Pacific Founders Fund-B, L.P. (\"Fund I-B\") at a price of $1.1180 per unit. Each unit consists of one share of Class A Common Stock, par value $0.0001 per share (the \"Common Stock\"), and 0.75 of a warrant (\"Common Warrants\") to purchase one share of Common Stock at an exercise price of $1.13. Each of Fund I, Fund I-A and Fund I-B elected to receive pre-funded warrants (\"Pre-Funded Warrants\", and together with Common Warrants, the \"Warrants\") to purchase Common Stock in lieu of a portion of their Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes (i) 4,223,621 shares of Common Stock directly acquired by Fund I, (ii) 164,046 shares of Common Stock directly acquired by Fund I-A, and (iii) 351,453 shares of Common Stock directly acquired by Fund I-B."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Chicago Pacific Founders UGP, LLC (\"UGP\") is the general partner of Chicago Founders GP, LP (\"GP\"), the general partner of each of Fund I, Fund I-A and Fund I-B. As a result, UGP has the power to vote and dispose of the Issuer's securities held by Fund I, Fund I-A and Fund I-B (the \"Underlying Securities\"). Each of UGP and GP disclaims beneficial ownership for the amount in excess of their pecuniary interest in the Underlying Securities."}],"balance_after":104740954,"source":{"system":"sec-edgar","filing":"0000899243-23-011890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898470/000089924323011890/doc4.xml","form_type":"4"}},{"id":2077868,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":114091,"kind":"organization","name":"Chicago Pacific Founders UGP, LLC","position":1,"cik":"0001897558","reported_name":"Chicago Pacific Founders UGP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114092,"kind":"organization","name":"Chicago Pacific Founders GP, L.P.","position":2,"cik":"0001898470","reported_name":"Chicago Pacific Founders GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to Purchase Class A Common Stock","published_at":"2022-12-22T16:25:20.000Z","date":"2022-12-13","kind":"purchase","acquired":true,"shares":429180,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 13, 2022, P3 Health Partners Inc. (the \"Issuer\") issued warrants to purchase 429,180 shares of Class A Common Stock to VBC Growth SPV LLC, a Delaware limited liability company (\"VBC\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The warrants were issued in connection with a promissory note issued by the Issuer to VBC providing for a financing in several tranches up to an aggregate of $40 million."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable immediately."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The warrants and the right to purchase securities upon the exercise of the warrants will terminate upon the earliest to occur of the following:  (a) December 13, 2027; and (b) the consummation of (i) a sale, conveyance, disposal, or encumbrance of all or substantially all of the Issuer's or P3 LLC's property or business or the Issuer's or P3 LLC's merger into or consolidation with any other corporation (other than a wholly owned subsidiary corporation) or (ii) any other transaction or series of related transactions in which more than fifty percent (50%) of the voting power of the Issuer or P3 LLC is disposed of."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Chicago Pacific Founders UGP, LLC (\"UGP\") is the general partner of Chicago Founders GP, LP, the general partner of CPF VBC Growth Aggregator, L.P., the sole manager of VBC.  As a result, UGP controls VBC and has the power to vote and dispose of the Issuer's securities held by VBC.  Affiliates of VBC also own a 66.81% member interest in VBC."}],"balance_after":429180,"derivative":{"exercise_price":4.26,"underlying":"Class A Common Stock","underlying_shares":429180},"source":{"system":"sec-edgar","filing":"0001062993-22-024411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898470/000106299322024411/form4.xml","form_type":"4"}}]}